Patent · US Expired

Vaccines

US7704514B2 · kind B2 · utility

9Cited by

7References

9Claims

0Family size

Assignee

Intercell AG · AT

Inventors

Michael Buschle · Perchtoldsdorf, AT
Andre Habel · Wien, AT
Jörge Fritz · Wien, AT
Karin Prinz · Eisenlohrsweg, AT
Karen Lingnau · Wien, AT

Key dates

Filing date	Mar 22, 2004
Grant date	Apr 27, 2010
Priority date	—
Expiry date	Jan 15, 2026

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention refers to an improved vaccine against infections with pathogens, especially viral pathogens, comprising an antigen, a peptide of the formula R1—XZXZN-XZX—R2 and an immunostimulatory deoxynucleic acid containing deoxyinosine and/or deoxyuridine residues.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.